US Stock MarketDetailed Quotes

CDLA Candela Medical

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 1 09:30 ET
0Market Cap0.00P/E (TTM)

Candela Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Total revenue
-17.48%321.65M
389.77M
Operating revenue
-17.48%321.65M
--389.77M
Cost of revenue
-17.21%182.57M
220.52M
Gross profit
-17.83%139.08M
169.25M
Operating expense
-17.46%159.12M
192.77M
Selling and administrative expenses
-18.35%135.59M
--166.07M
-Selling and marketing expense
-30.69%85.74M
--123.7M
-General and administrative expense
17.66%49.85M
--42.37M
Research and development costs
-11.89%23.53M
--26.7M
Operating profit
14.79%-20.04M
-23.52M
Net non-operating interest income expense
-365.02%-12.43M
-2.67M
Non-operating interest expense
365.02%12.43M
--2.67M
Other net income (expense)
-672.66%-2.97M
-384K
Gain on sale of security
-760.24%-3.53M
---410K
Special income (charges)
38.36%-810K
---1.31M
-Gain on sale of property,plant,equipment
38.36%-810K
---1.31M
Other non- operating income (expenses)
2.24%1.37M
--1.34M
Income before tax
-33.34%-35.44M
-26.58M
Income tax
1.70%8.45M
8.31M
Net income
-25.80%-43.89M
-34.89M
Net income continuous Operations
-25.80%-43.89M
---34.89M
Minority interest income
Net income attributable to the parent company
-25.80%-43.89M
-34.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.80%-43.89M
-34.89M
Basic earnings per share
-25.74%-0.449
-0.3571
Diluted earnings per share
-25.74%-0.449
-0.3571
Dividend per share
Currency Unit
USD
USD
Audit Opinions
Unqualified Opinion
--
(FY)Dec 31, 2020(FY)Dec 31, 2019
Total revenue -17.48%321.65M389.77M
Operating revenue -17.48%321.65M--389.77M
Cost of revenue -17.21%182.57M220.52M
Gross profit -17.83%139.08M169.25M
Operating expense -17.46%159.12M192.77M
Selling and administrative expenses -18.35%135.59M--166.07M
-Selling and marketing expense -30.69%85.74M--123.7M
-General and administrative expense 17.66%49.85M--42.37M
Research and development costs -11.89%23.53M--26.7M
Operating profit 14.79%-20.04M-23.52M
Net non-operating interest income expense -365.02%-12.43M-2.67M
Non-operating interest expense 365.02%12.43M--2.67M
Other net income (expense) -672.66%-2.97M-384K
Gain on sale of security -760.24%-3.53M---410K
Special income (charges) 38.36%-810K---1.31M
-Gain on sale of property,plant,equipment 38.36%-810K---1.31M
Other non- operating income (expenses) 2.24%1.37M--1.34M
Income before tax -33.34%-35.44M-26.58M
Income tax 1.70%8.45M8.31M
Net income -25.80%-43.89M-34.89M
Net income continuous Operations -25.80%-43.89M---34.89M
Minority interest income
Net income attributable to the parent company -25.80%-43.89M-34.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.80%-43.89M-34.89M
Basic earnings per share -25.74%-0.449-0.3571
Diluted earnings per share -25.74%-0.449-0.3571
Dividend per share
Currency Unit USDUSD
Audit Opinions Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data